Basic Information
RNALocate ID: | RLID:11001782 |
RNA Symbol: | hsa-miR-142-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-142-5p |
RNA ID: | miRBase:MIMAT0000433 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001785 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
RLID:11001776 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
RLID:11001777 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001778 | Exosome | Renal cancer cells | 21670082 |
RLID:11001779 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
RLID:11001780 | Exosome | Breast milk | 22211110 |
RLID:11001781 | Exosome | Brain tissue | 23382797 |
RLID:11001783 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001785 | Microvesicle | Liver resident stem cells | 20668554 |
RLID:11001786 | Microvesicle | Plasma | 23077538 |
RLID-D:11000083 | Exosome | Blood|B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells | |
RLID-D:11000361 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-142-5p | Mantle cell lymphoma | MNDR-E-MI-14022 |
MNDR | hsa-miR-142-5p | Splenic marginal zone lymphoma | MNDR-E-MI-14023 |
MNDR | hsa-miR-142-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-14024 |
MNDR | hsa-miR-142-5p | Oral squamous cell carcinoma | MNDR-E-MI-14025 |
MNDR | hsa-miR-142-5p | Medulloblastoma | MNDR-E-MI-14026 |
MNDR | hsa-miR-142-5p | Malt lymphoma | MNDR-E-MI-14027 |
MNDR | hsa-miR-142-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-14028 |
MNDR | hsa-miR-142-5p | Lymphoma | MNDR-E-MI-14029 |
MNDR | hsa-miR-142-5p | Lymphoma non-hodgkin | MNDR-E-MI-14030 |
MNDR | hsa-miR-142-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-14031 |
MNDR | hsa-miR-142-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-14032 |
MNDR | hsa-miR-142-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-14033 |
MNDR | hsa-miR-142-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-14034 |
MNDR | hsa-miR-142-5p | Her2-receptor positive breast cancer | MNDR-E-MI-14035 |
MNDR | hsa-miR-142-5p | Breast cancer luminal | MNDR-E-MI-14036 |
MNDR | hsa-miR-142-5p | Lupus nephritis | MNDR-E-MI-14037 |
MNDR | hsa-miR-142-5p | Dermatomyositis | MNDR-E-MI-14038 |
MNDR | hsa-miR-142-5p | Prostate cancer | MNDR-E-MI-14039 |
MNDR | hsa-miR-142-5p | Hirschsprung disease | MNDR-E-MI-14040 |
MNDR | hsa-miR-142-5p | Gastric lymphoma | MNDR-E-MI-14041 |
MNDR | hsa-miR-142-5p | Alzheimer disease | MNDR-E-MI-14042 |
MNDR | hsa-miR-142-5p | Intracranial aneurysm | MNDR-E-MI-14043 |
MNDR | hsa-miR-142-5p | Esophageal carcinoma | MNDR-E-MI-14044 |
MNDR | hsa-miR-142-5p | Head and neck cancer | MNDR-E-MI-14045 |
MNDR | hsa-miR-142-5p | Malaria | MNDR-E-MI-14046 |
MNDR | hsa-miR-142-5p | Leukemia | MNDR-E-MI-14047 |
MNDR | hsa-miR-142-5p | Huntington disease | MNDR-E-MI-14048 |
MNDR | hsa-miR-142-5p | Chorea | MNDR-E-MI-14049 |
MNDR | hsa-miR-142-5p | Cardiovascular disease | MNDR-E-MI-14050 |
MNDR | hsa-miR-142-5p | Lung cancer | MNDR-E-MI-14051 |
MNDR | hsa-miR-142-5p | Parkinson disease | MNDR-E-MI-14052 |
MNDR | hsa-miR-142-5p | Machado-joseph disease | MNDR-E-MI-14053 |
MNDR | hsa-miR-142-5p | Basal-like breast cancer | MNDR-E-MI-14054 |
MNDR | hsa-miR-142-5p | Pancreatic cancer | MNDR-E-MI-14055 |
MNDR | hsa-miR-142-5p | Melanoma | MNDR-E-MI-14056 |
MNDR | hsa-miR-142-5p | Rectum adenocarcinoma | MNDR-E-MI-14057 |
MNDR | hsa-miR-142-5p | Nephroblastoma | MNDR-E-MI-14058 |
MNDR | hsa-miR-142-5p | Colon cancer | MNDR-E-MI-14059 |
MNDR | hsa-miR-142-5p | Colon adenocarcinoma | MNDR-E-MI-14060 |
MNDR | hsa-miR-142-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-14061 |
MNDR | hsa-miR-142-5p | Familial ovarian cancer | MNDR-E-MI-14062 |
MNDR | hsa-miR-142-5p | Carcinoma ductal breast | MNDR-E-MI-14063 |
MNDR | hsa-miR-142-5p | Glioblastoma | MNDR-E-MI-14064 |
MNDR | hsa-miR-142-5p | Malignant glioma | MNDR-E-MI-14065 |
MNDR | hsa-miR-142-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-14066 |
MNDR | hsa-miR-142-5p | Osteosarcoma | MNDR-E-MI-14067 |
MNDR | hsa-miR-142-5p | Inclusion body myositis | MNDR-E-MI-14068 |
MNDR | hsa-miR-142-5p | Breast carcinoma | MNDR-E-MI-14069 |
MNDR | hsa-miR-142-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-14070 |
MNDR | hsa-miR-142-5p | Meningioma | MNDR-E-MI-14071 |
MNDR | hsa-miR-142-5p | Uterine cancer | MNDR-E-MI-14072 |
MNDR | hsa-miR-142-5p | Gastric adenocarcinoma | MNDR-E-MI-14073 |
MNDR | hsa-miR-142-5p | Cervical squamous cell carcinoma | MNDR-E-MI-14074 |
MNDR | hsa-miR-142-5p | Lung squamous cell carcinoma | MNDR-E-MI-14075 |
MNDR | hsa-miR-142-5p | Non-small cell lung cancer | MNDR-E-MI-14076 |
MNDR | hsa-miR-142-5p | Lung adenocarcinoma | MNDR-E-MI-14077 |
MNDR | hsa-miR-142-5p | Adrenocortical carcinoma | MNDR-E-MI-14078 |
MNDR | hsa-miR-142-5p | Thyroid carcinoma | MNDR-E-MI-14079 |
MNDR | hsa-miR-142-5p | Pancreatic adenocarcinoma | MNDR-E-MI-14080 |
MNDR | hsa-miR-142-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-14081 |
MNDR | hsa-miR-142-5p | Carcinoma renal cell | MNDR-E-MI-14082 |
MNDR | hsa-miR-142-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-14083 |
MNDR | hsa-miR-142-5p | Clear cell renal cell cancer | MNDR-E-MI-14084 |
MNDR | hsa-miR-142-5p | Cholangiocarcinoma | MNDR-E-MI-14085 |
MNDR | hsa-miR-142-5p | Esophageal cancer | MNDR-E-MI-14086 |
MNDR | hsa-miR-142-5p | Lung small cell carcinoma | MNDR-E-MI-14087 |
MNDR | hsa-miR-142-5p | Testicular germ cell cancer | MNDR-E-MI-14088 |
MNDR | hsa-miR-142-5p | Kidney diseases | MNDR-E-MI-14089 |
MNDR | hsa-miR-142-5p | Breast invasive carcinoma | MNDR-E-MI-14090 |
MNDR | hsa-miR-142-5p | Hepatocellular carcinoma | MNDR-E-MI-14091 |
MNDR | hsa-miR-142-5p | Familiar ovarian carcinoma | MNDR-E-MI-14092 |
MNDR | hsa-miR-142-5p | B-cell lymphoma | MNDR-E-MI-14093 |
MNDR | hsa-miR-142-5p | Rheumatoid arthritis | MNDR-E-MI-14094 |
MNDR | hsa-miR-142-5p | T-cell leukemia | MNDR-E-MI-14095 |
MNDR | hsa-miR-142-5p | Retinoblastoma | MNDR-E-MI-14096 |
MNDR | hsa-miR-142-5p | Barrett's adenocarcinoma | MNDR-E-MI-14097 |
MNDR | hsa-miR-142-5p | Chronic fatigue syndrome | MNDR-E-MI-14098 |
MNDR | hsa-miR-142-5p | Hodgkin lymphoma | MNDR-E-MI-14099 |
MNDR | hsa-miR-142-5p | Ulcerative colitis | MNDR-E-MI-14100 |
MNDR | hsa-miR-142-5p | Burkitt lymphoma | MNDR-E-MI-14101 |
MNDR | hsa-miR-142-5p | Dementia vascular | MNDR-E-MI-14102 |
MNDR | hsa-miR-142-5p | Tonsil cancer | MNDR-E-MI-14103 |
MNDR | hsa-miR-142-5p | Neuromyelitis optica | MNDR-E-MI-14104 |
MNDR | hsa-miR-142-5p | Skin cutaneous melanoma | MNDR-E-MI-14105 |
MNDR | hsa-miR-142-5p | Skin melanoma | MNDR-E-MI-14106 |
MNDR | hsa-miR-142-5p | Acute myeloid leukemia | MNDR-E-MI-14107 |
MNDR | hsa-miR-142-5p | Colorectal cancer | MNDR-E-MI-14108 |
MNDR | hsa-miR-142-5p | Nasopharynx carcinoma | MNDR-E-MI-14109 |
MNDR | hsa-miR-142-5p | Multiple myeloma | MNDR-E-MI-14110 |
MNDR | hsa-miR-142-5p | Fever | MNDR-E-MI-14111 |
MNDR | hsa-miR-142-5p | Cardiac hypertrophy | MNDR-E-MI-14112 |
MNDR | hsa-miR-142-5p | Nasopharyngeal cancer | MNDR-E-MI-14113 |
MNDR | hsa-miR-142-5p | Aids dementia complex | MNDR-E-MI-14114 |
MNDR | hsa-miR-142-5p | Stroke lacunar | MNDR-E-MI-14115 |
MNDR | hsa-miR-142-5p | Barrett's carcinogenesis | MNDR-E-MI-14116 |
MNDR | hsa-miR-142-5p | Breast cancer her3+ negative | MNDR-E-MI-14117 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AGER | Homo sapiens | RR00054545 |
TOP